Btg Pactual Global Asset Management LTD Agios Pharmaceuticals, Inc. Transaction History

Btg Pactual Global Asset Management LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$42.73 - $76.53 $121,267 - $217,192	-2,838 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$71.67 - $91.95 $411,959 - $528,528	-5,748 Reduced 66.95%	2,838 $219,000
Q2 2018 Aug 14, 2018	BUY	$73.22 - $99.55 $44,444 - $60,426	607 Added 7.61%	8,586 $723,000
Q1 2018 May 15, 2018	SELL	$59.83 - $86.53 $19,444 - $28,122	-325 Reduced 3.91%	7,979 $653,000
Q4 2017 Feb 14, 2018	BUY	$52.12 - $72.33 $14,645 - $20,324	281 Added 3.5%	8,304 $475,000
Q3 2017 Nov 14, 2017	SELL	$54.89 - $67.12 $18,497 - $22,619	-337 Reduced 4.03%	8,023 $536,000
Q2 2017 Aug 14, 2017	BUY	N/A	8,360	8,360 $430,000

233

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.74B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Btg Pactual Global Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Btg Pactual Global Asset Management LTD with notifications on news.